Frequent development of combined pituitary hormone deficiency in patients initially diagnosed as isolated growth hormone deficiency: a long term follow-up of patients from a single center

Pituitary. 2015 Aug;18(4):561-7. doi: 10.1007/s11102-014-0610-9.

Abstract

Background: Children initially diagnosed with isolated GH deficiency (IGHD) have a variable rate to progress to combined pituitary hormone deficiency (CPHD) during follow-up.

Objective: To evaluate the development of CPHD in a group of childhood-onset IGHD followed at a single tertiary center over a long period of time.

Patients and methods: We retrospectively analyzed data from 83 patients initially diagnosed as IGHD with a mean follow-up of 15.2 years. The Kaplan-Meier method and Cox regression analysis was used to estimate the temporal progression and to identify risk factors to development of CPHD over time.

Results: From 83 patients initially with IGHD, 37 (45%) developed CPHD after a median time of follow up of 5.4 years (range from 1.2 to 21 years). LH and FSH deficiencies were the most common pituitary hormone (38%) deficiencies developed followed by TSH (31%), ACTH (12%) and ADH deficiency (5%). ADH deficiency (3.1 ± 1 years from GHD diagnosis) presented earlier and ACTH deficiency (9.3 ± 3.5 years) presented later during follow up compared to LH/FSH (8.3 ± 4 years) and TSH (7.5 ± 5.6 years) deficiencies. In a Cox regression model, pituitary stalk abnormalities was the strongest risk factor for the development of CPHD (hazard ratio of 3.28; p = 0.002).

Conclusion: Our study indicated a high frequency of development of CPHD in patients initially diagnosed as IGHD at childhood. Half of our patients with IGHD developed the second hormone deficiency after 5 years of diagnosis, reinforcing the need for lifelong monitoring of pituitary function in these patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenocorticotropic Hormone / deficiency*
  • Adult
  • Child
  • Child, Preschool
  • Cohort Studies
  • Disease Progression
  • Dwarfism, Pituitary / epidemiology*
  • Female
  • Follicle Stimulating Hormone / deficiency*
  • Follow-Up Studies
  • Human Growth Hormone / deficiency*
  • Humans
  • Hypopituitarism / epidemiology*
  • Hypopituitarism / pathology
  • Hypothalamus / pathology
  • Kaplan-Meier Estimate
  • Longitudinal Studies
  • Luteinizing Hormone / deficiency*
  • Magnetic Resonance Imaging
  • Male
  • Pituitary Gland / pathology
  • Proportional Hazards Models
  • Retrospective Studies
  • Thyrotropin / deficiency*
  • Time Factors
  • Vasopressins / deficiency*
  • Young Adult

Substances

  • Vasopressins
  • Human Growth Hormone
  • Adrenocorticotropic Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Thyrotropin

Supplementary concepts

  • Combined Pituitary Hormone Deficiency